Click here for a PDF of the release.
Click here for Q2 2015 Supplemental Information.
Announces
Completes
Grows U.S. Seniors Housing Operating Same Store Cash NOI 5.2%
“We are playing a key role in driving the evolution of health care and solving the challenges of caring for an aging population. We enter the second half of the year having announced
Earnings Results For the quarter, we generated normalized FFO and FAD per share of
Dividend Growth As previously announced, the Board of Directors declared a cash dividend for the quarter ended
Capital Activity On
Outlook for 2015 We reaffirm our 2015 earnings guidance and expect to report normalized FFO in a range of
- Same Store Cash NOI: We continue to expect blended SSCNOI growth of approximately 3.0%-3.5% in 2015.
- Acquisitions: 2015 earnings guidance includes only those acquisitions which have been completed or announced, comprised of acquisitions completed in the first half of the year, the Revera and Genesis investments discussed below, and investments associated with the Mainstreet partnership.
- Development: We anticipate funding additional development of
$170 million in 2015 relating to projects underway onJune 30, 2015 . We expect development conversions of approximately$63 million in the remainder of 2015. These investments are currently expected to generate yields of approximately 9.0%. - Dispositions: We continue to expect 2015 dispositions of approximately
$1 billion of pro rata proceeds at an average yield on proceeds of 7%.
Net income attributable to common stockholders guidance has been decreased to a range of
Investment Activity We completed
Notable Investments with
Beverly Hills Portfolio We completed a follow-on transaction with an existing relationship to acquire a portfolio of eight outpatient medical properties. The purchase price based on a 100% ownership interest was
Avery Healthcare We extended our relationship with Avery by acquiring a 100% private pay seniors housing property with 80 units built in 2013 at a purchase price of £12.3 million. Avery is an existing partner and one of our Top 10 operators. The property was added to the existing Avery master lease at an initial lease yield of 6.9% with 3.0% annual escalators. The stabilized payment coverage after management fee is expected to be 1.35x. The property is located in
Cascade Living Group We acquired nine seniors housing properties with 535 units in
Genesis Healthcare We expanded our partnership with Genesis by acquiring a 90-bed PowerBack property in the Dallas MSA for
Legend Senior Living We acquired two private pay seniors housing properties in an acquisition/leaseback transaction with Legend. The properties contain 148 total units and are located in the Dallas MSA. The
Senior
Symphony/Mainstreet We extended our relationship with Mainstreet and established a new relationship with Symphony through the acquisition of a 100-bed post-acute property located in the Chicago MSA for
Trilogy/Mainstreet We extended our relationship with Mainstreet through the acquisition of two post-acute properties, a 94-bed property located in an affluent suburb of
Notable Investments with
EPOCH Senior Living We partnered with EPOCH to acquire three private pay seniors housing properties with 230 units. The purchase price based on a 100% ownership interest was
Notable Development Conversions
Brandywine Senior Living We partnered with Brandywine to fund the development of three seniors housing properties comprising 244 units that were completed during the second quarter. Two are located in the Philadelphia MSA and one is in the New York MSA. Both are core markets for HCN and Brandywine. The total investment amount was
Sagora Senior Living We completed a 32-unit expansion to a highly occupied seniors housing property that we lease to Sagora in
Signature Senior Lifestyle We completed funding construction of an 85-unit seniors housing property operated by Signature in
Sunrise Senior Living We expanded our relationship with Sunrise through the completion of a £13.3 million, 70-unit seniors housing development located in
Notable Dispositions
We sold our 49% interest in seven life science buildings with 1.2 million square feet for
Investments Announced But Not Yet Closed
Revera As previously announced, we entered into a definitive agreement to acquire
Genesis Healthcare As previously announced, Genesis has entered into a definitive agreement to acquire a portfolio of 24 long-term/post-acute properties in the U.S. from Revera. HCN expects to fund up to
Conference Call Information We have scheduled a conference call on
Supplemental Reporting Measures We believe that net income attributable to common stockholders (NICS), as defined by U.S. generally accepted accounting principles (U.S. GAAP), is the most appropriate earnings measurement. However, we consider funds from operations (FFO) and funds available for distribution (FAD) to be useful supplemental measures of our operating performance. Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the
About
Forward-Looking Statements and Risk Factors This document contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. When we use words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, we are making forward-looking statements. In particular, these forward-looking statements include, but are not limited to, those relating to our opportunities to acquire, develop or sell properties; our ability to close anticipated acquisitions, investments or dispositions on currently anticipated terms, or within currently anticipated timeframes; the expected performance of our operators/tenants and properties; our expected occupancy rates; our ability to declare and to make distributions to shareholders; our investment and financing opportunities and plans; our continued qualification as a real estate investment trust (“REIT”); our ability to access capital markets or other sources of funds; and our ability to meet our earnings guidance. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause our actual results to differ materially from our expectations discussed in the forward-looking statements. This may be a result of various factors, including, but not limited to: the status of the economy; the status of capital markets, including availability and cost of capital; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies, responding to government investigations and punitive settlements and operators’/tenants’ difficulty in cost-effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care and seniors housing industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; our ability to transition or sell properties with profitable results; the failure to make new investments or acquisitions as and when anticipated; natural disasters and other acts of God affecting our properties; our ability to re-lease space at similar rates as vacancies occur; our ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant or joint venture partner bankruptcies or insolvencies; the cooperation of joint venture partners; government regulations affecting
HEALTH CARE REIT, INC. |
|||||||||||
Consolidated Balance Sheets (unaudited) | |||||||||||
(in thousands) | |||||||||||
June 30, | |||||||||||
2015 | 2014 | ||||||||||
Assets | |||||||||||
Real estate investments: | |||||||||||
Land and land improvements | $ | 2,244,048 | $ | 1,916,820 | |||||||
Buildings and improvements | 24,097,963 | 21,151,624 | |||||||||
Acquired lease intangibles | 1,214,628 | 1,084,703 | |||||||||
Real property held for sale, net of accumulated depreciation | 352,113 | 77,436 | |||||||||
Construction in progress | 159,352 | 124,073 | |||||||||
28,068,104 | 24,354,656 | ||||||||||
Less accumulated depreciation and intangible amortization | (3,363,834 | ) | (2,809,530 | ) | |||||||
Net real property owned | 24,704,270 | 21,545,126 | |||||||||
Real estate loans receivable(1) | 760,543 | 367,186 | |||||||||
Net real estate investments | 25,464,813 | 21,912,312 | |||||||||
Other assets: | |||||||||||
Investments in unconsolidated entities | 569,621 | 680,558 | |||||||||
Goodwill | 68,321 | 68,321 | |||||||||
Deferred loan expenses | 65,727 | 65,479 | |||||||||
Cash and cash equivalents | 217,942 | 207,354 | |||||||||
Restricted cash | 72,706 | 65,139 | |||||||||
Straight-line rent receivable | 336,853 | 231,668 | |||||||||
Receivables and other assets | 611,499 | 343,059 | |||||||||
1,942,669 | 1,661,578 | ||||||||||
Total assets | $ | 27,407,482 | $ | 23,573,890 | |||||||
Liabilities and equity | |||||||||||
Liabilities: | |||||||||||
Borrowings under primary unsecured credit facility | $ | 350,000 | $ | - | |||||||
Senior unsecured notes | 8,060,493 | 7,411,243 | |||||||||
Secured debt | 3,066,633 | 2,850,103 | |||||||||
Capital lease obligations | 75,240 | 83,850 | |||||||||
Accrued expenses and other liabilities | 650,437 | 678,400 | |||||||||
Total liabilities | 12,202,803 | 11,023,596 | |||||||||
Redeemable noncontrolling interests | 159,400 | 35,404 | |||||||||
Equity: | |||||||||||
Preferred stock | 1,006,250 | 1,006,250 | |||||||||
Common stock | 351,651 | 308,355 | |||||||||
Capital in excess of par value | 16,300,841 | 13,524,621 | |||||||||
Treasury stock | (41,693 | ) | (32,289 | ) | |||||||
Cumulative net income | 3,378,096 | 2,484,425 | |||||||||
Cumulative dividends | (6,230,540 | ) | (5,096,110 | ) | |||||||
Accumulated other comprehensive income | (81,670 | ) | (18,642 | ) | |||||||
Other equity | 4,238 | 6,159 | |||||||||
Total Health Care REIT, Inc. stockholders’ equity | 14,687,173 | 12,182,769 | |||||||||
Noncontrolling interests | 358,106 | 332,121 | |||||||||
Total equity | 15,045,279 | 12,514,890 | |||||||||
Total liabilities and equity | $ | 27,407,482 | $ | 23,573,890 | |||||||
(1) | Includes non-accrual loan balances of $21,000,000 and $0 at June 30, 2015 and 2014, respectively. | |
Consolidated Statements of Income (unaudited) | |||||||||||||||||||
(in thousands, except per share data) | |||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||
June 30, | June 30, | ||||||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||||
Revenues: | |||||||||||||||||||
Rental income | $ | 396,626 | $ | 347,847 | $ | 776,213 | $ | 684,303 | |||||||||||
Resident fees and service | 535,553 | 467,639 | 1,028,063 | 923,904 | |||||||||||||||
Interest income | 20,576 | 8,933 | 37,570 | 17,527 | |||||||||||||||
Other income | 4,414 | 2,027 | 9,500 | 2,520 | |||||||||||||||
Gross revenues | 957,169 | 826,446 | 1,851,346 | 1,628,254 | |||||||||||||||
Expenses: | |||||||||||||||||||
Interest expense | 118,861 | 121,065 | 239,942 | 241,898 | |||||||||||||||
Property operating expenses | 398,354 | 343,754 | 774,815 | 685,185 | |||||||||||||||
Depreciation and amortization | 208,802 | 214,449 | 397,631 | 447,766 | |||||||||||||||
General and administrative expenses | 38,474 | 51,660 | 73,612 | 84,524 | |||||||||||||||
Transaction costs | 12,491 | 7,040 | 61,045 | 7,993 | |||||||||||||||
Loss (gain) on derivatives, net | - | 351 | (58,427 | ) | 351 | ||||||||||||||
Loss (gain) on extinguishment of debt, net | 18,887 | 531 | 34,288 | 383 | |||||||||||||||
Impairment of assets | - | - | 2,220 | - | |||||||||||||||
Other expenses | 10,583 | - | 10,583 | - | |||||||||||||||
Total expenses | 806,452 | 738,850 | 1,535,709 | 1,468,100 | |||||||||||||||
Income (loss) from continuing operations before income taxes | |||||||||||||||||||
and income from unconsolidated entities | 150,717 | 87,596 | 315,637 | 160,154 | |||||||||||||||
Income tax (expense) benefit | (7,417 | ) | (1,569 | ) | (7,113 | ) | (3,830 | ) | |||||||||||
Income (loss) from unconsolidated entities | (2,952 | ) | (11,516 | ) | (15,600 | ) | (17,073 | ) | |||||||||||
Income (loss) from continuing operations | 140,348 | 74,511 | 292,924 | 139,251 | |||||||||||||||
Discontinued operations, net | - | 6,675 |
- |
7,135 | |||||||||||||||
Gain (loss) on real estate dispositions, net | 190,111 | 6,668 | 246,956 | 6,668 | |||||||||||||||
Net income (loss) | 330,459 | 87,854 | 539,880 | 153,054 | |||||||||||||||
Less: | Preferred dividends | 16,352 | 16,352 | 32,703 | 32,705 | ||||||||||||||
Net income (loss) attributable to noncontrolling interests | 1,534 | (327 | ) | 3,804 | (1,502 | ) | |||||||||||||
Net income (loss) attributable to common stockholders | $ | 312,573 | $ | 71,829 | $ | 503,373 | $ | 121,851 | |||||||||||
Average number of common shares outstanding: | |||||||||||||||||||
Basic | 350,399 | 296,256 | 343,624 | 293,046 | |||||||||||||||
Diluted | 351,366 | 297,995 | 344,623 | 294,590 | |||||||||||||||
Net income (loss) attributable to common stockholders per share: | |||||||||||||||||||
Basic | $ | 0.89 | $ | 0.24 | $ | 1.46 | $ | 0.42 | |||||||||||
Diluted | $ | 0.89 | $ | 0.24 | $ | 1.46 | $ | 0.41 | |||||||||||
Common dividends per share | $ | 0.825 | $ | 0.795 | $ | 1.65 | $ | 1.59 | |||||||||||
Normalizing Items |
Exhibit 1 | |||||||||||||||
(in thousands, except per share data) | Three Months Ended | Six Months Ended | ||||||||||||||
June 30, | June 30, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Transaction costs | $ |
12,491 (1) |
$ | 7,040 | $ | 61,045 | $ | 7,993 | ||||||||
Loss (gain) on derivatives, net | - | 351 | (58,427 | ) | 351 | |||||||||||
Loss (gain) on extinguishment of debt, net |
18,887 (2) |
531 | 34,288 | 383 | ||||||||||||
CEO transition costs | - | 19,688 | - | 19,688 | ||||||||||||
Nonrecurring income tax benefits | - | - | - | - | ||||||||||||
Other expenses |
10,583 (3) |
- | 11,278 | - | ||||||||||||
Additional other income | - | - | (2,144 | ) | - | |||||||||||
Normalizing items attributable to noncontrolling interests and unconsolidated entities, net |
1,151 (4) |
4,502 | 2,485 | 4,607 | ||||||||||||
Total | $ | 43,112 | $ | 32,112 | $ | 48,525 | $ | 33,022 | ||||||||
Average diluted common shares outstanding | 351,366 | 297,995 | 344,623 | 294,590 | ||||||||||||
Net amount per diluted share | $ | 0.12 | $ | 0.11 | $ | 0.14 | $ | 0.11 | ||||||||
Notes: | (1) Primarily costs incurred with triple-net transactions. | |||
(2) Primarily related to early extinguishment of 2016 senior unsecured notes. | ||||
(3) Due to the termination of our investment in a strategic medical office partnership and costs associated with the retirement of an executive officer. | ||||
(4) Primarily related to transaction costs incurred with unconsolidated seniors housing investments. | ||||
Funds Available for Distribution Reconciliation |
Exhibit 2 | ||||||||||||||||||
(in thousands, except per share data) | Three Months Ended | Six Months Ended | |||||||||||||||||
June 30, | June 30, | ||||||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||||
Net income (loss) attributable to common stockholders | $ | 312,573 | $ | 71,829 | $ | 503,373 | $ | 121,851 | |||||||||||
Depreciation and amortization | 208,802 | 214,449 | 397,631 | 447,766 | |||||||||||||||
Losses/impairments (gains) on properties, net | (190,111 | ) | (13,079 | ) | (244,736 | ) | (13,079 | ) | |||||||||||
Noncontrolling interests(1) | (9,447 | ) | (8,361 | ) | (15,786 | ) | (17,885 | ) | |||||||||||
Unconsolidated entities(2) | 16,908 | 18,881 | 42,744 | 33,304 | |||||||||||||||
Gross straight-line rental income | (31,190 | ) | (22,958 | ) | (59,727 | ) | (39,550 | ) | |||||||||||
Amortization related to above (below) market leases, net | 757 | 280 | 870 | 365 | |||||||||||||||
Non-cash interest expense | (4,202 | ) | 1,649 | (4,082 | ) | 1,980 | |||||||||||||
Cap-ex, tenant improvements, lease commissions | (15,114 | ) | (13,796 | ) | (25,599 | ) | (26,188 | ) | |||||||||||
Funds available for distribution | 288,976 | 248,894 | 594,688 | 508,564 | |||||||||||||||
Normalizing items, net(3) | 43,112 | 32,112 | 48,525 | 33,022 | |||||||||||||||
Funds available for distribution - normalized | $ | 332,088 | $ | 281,006 | $ | 643,213 | $ | 541,586 | |||||||||||
Average diluted common shares outstanding | 351,366 | 297,995 | 344,623 | 294,590 | |||||||||||||||
Per share data: | |||||||||||||||||||
Net income (loss) attributable to common stockholders | $ | 0.89 | $ | 0.24 | $ | 1.46 | $ | 0.41 | |||||||||||
Funds available for distribution | $ | 0.82 | $ | 0.84 | $ | 1.73 | $ | 1.73 | |||||||||||
Funds available for distribution - normalized | $ | 0.95 | $ | 0.94 | $ | 1.87 | $ | 1.84 | |||||||||||
Normalized FAD Payout Ratio: | |||||||||||||||||||
Dividends per common share | $ | 0.825 | $ | 0.795 | $ | 1.65 | $ | 1.59 | |||||||||||
FAD per diluted share - normalized | $ | 0.95 | $ | 0.94 | $ | 1.87 | $ | 1.84 | |||||||||||
Normalized FAD payout ratio | 87 | % | 85 | % | 88 | % | 86 | % | |||||||||||
Notes: | (1) Represents noncontrolling interests' share of net FAD adjustments. | |||
(2) Represents HCN's share of net FAD adjustments from unconsolidated entities. | ||||
(3) See Exhibit 1. | ||||
Funds From Operations Reconciliation |
Exhibit 3 | ||||||||||||||||||
(in thousands, except per share data) | Three Months Ended | Six Months Ended | |||||||||||||||||
June 30, | June 30, | ||||||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||||
Net income (loss) attributable to common stockholders | $ | 312,573 | $ | 71,829 | $ | 503,373 | $ | 121,851 | |||||||||||
Depreciation and amortization | 208,802 | 214,449 | 397,631 | 447,766 | |||||||||||||||
Losses/impairments (gains) on properties, net | (190,111 | ) | (13,079 | ) | (244,736 | ) | (13,079 | ) | |||||||||||
Noncontrolling interests(1) | (10,467 | ) | (9,741 | ) | (17,716 | ) | (20,259 | ) | |||||||||||
Unconsolidated entities(2) | 19,791 | 20,787 | 46,287 | 36,770 | |||||||||||||||
Funds from operations - NAREIT | 340,588 | 284,245 | 684,839 | 573,049 | |||||||||||||||
Normalizing items, net(3) | 43,112 | 32,112 | 48,525 | 33,022 | |||||||||||||||
Funds from operations - normalized | $ | 383,700 | $ | 316,357 | $ | 733,364 | $ | 606,071 | |||||||||||
Average diluted common shares outstanding | 351,366 | 297,995 | 344,623 | 294,590 | |||||||||||||||
Per share data: | |||||||||||||||||||
Net income (loss) attributable to common stockholders | $ | 0.89 | $ | 0.24 | $ | 1.46 | $ | 0.41 | |||||||||||
Funds from operations - NAREIT | $ | 0.97 | $ | 0.95 | $ | 1.99 | $ | 1.95 | |||||||||||
Funds from operations - normalized | $ | 1.09 | $ | 1.06 | $ | 2.13 | $ | 2.06 | |||||||||||
Normalized FFO Payout Ratio: | |||||||||||||||||||
Dividends per common share | $ | 0.825 | $ | 0.795 | $ | 1.65 | $ | 1.59 | |||||||||||
FFO per diluted share - normalized | $ | 1.09 | $ | 1.06 | $ | 2.13 | $ | 2.06 | |||||||||||
Normalized FFO payout ratio | 76 | % | 75 | % | 77 | % | 77 | % | |||||||||||
Notes: | (1) Represents noncontrolling interests' share of net FFO adjustments. | |||
(2) Represents HCN's share of net FFO adjustments from unconsolidated entities. | ||||
(3) See Exhibit 1. | ||||
Outlook Reconciliations: Year Ended December 31, 2015 |
Exhibit 4 | ||||||||||||||||||
(dollars per fully diluted share) | |||||||||||||||||||
Prior Outlook | Current Outlook | ||||||||||||||||||
Low | High | Low | High | ||||||||||||||||
FFO Reconciliation: |
|||||||||||||||||||
Net income attributable to common stockholders | $ | 2.62 | $ | 2.72 | $ | 2.47 | $ | 2.57 | |||||||||||
Losses/impairments (gains) on sales, net(1,2) | (0.78 | ) | (0.78 | ) | (0.79 | ) | (0.79 | ) | |||||||||||
Depreciation and amortization(1) | 2.39 | 2.39 | 2.43 | 2.43 | |||||||||||||||
Funds from operations - NAREIT | $ | 4.23 | $ | 4.33 | $ | 4.11 | $ | 4.21 | |||||||||||
Normalizing items, net(3) | 0.02 | 0.02 | 0.14 | 0.14 | |||||||||||||||
Funds from operations - normalized | $ | 4.25 | $ | 4.35 | $ | 4.25 | $ | 4.35 | |||||||||||
FAD Reconciliation: |
|||||||||||||||||||
Net income attributable to common stockholders | $ | 2.62 | $ | 2.72 | $ | 2.47 | $ | 2.57 | |||||||||||
Losses/impairments (gains) on sales, net(1,2) | (0.78 | ) | (0.78 | ) | (0.79 | ) | (0.79 | ) | |||||||||||
Depreciation and amortization(1) | 2.39 | 2.39 | 2.43 | 2.43 | |||||||||||||||
FAD-only adjustments(1,4) | (0.42 | ) | (0.42 | ) | (0.42 | ) | (0.42 | ) | |||||||||||
Funds available for distribution | $ | 3.81 | $ | 3.91 | $ | 3.69 | $ | 3.79 | |||||||||||
Normalizing items, net(3) | 0.02 | 0.02 | 0.14 | 0.14 | |||||||||||||||
Funds available for distribution - normalized | $ | 3.83 | $ | 3.93 | $ | 3.83 | $ | 3.93 | |||||||||||
Notes: | (1) Amounts presented net of noncontrolling interests' share and HCN's share of unconsolidated entities. | |||
(2) Includes estimated gains on expected dispositions. | ||||
(3) See Exhibit 1. | ||||
(4) Includes straight-line rent, above/below amortization, non-cash interest and cap-ex, tenant improvements and lease commissions. | ||||
View source version on businesswire.com: http://www.businesswire.com/news/home/20150804005437/en/
Source:
Health Care REIT, Inc.
Scott Estes, 419-247-2800